|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 1 97-103, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
R Ohara, S Hirota, H Onoue, S Nomura, Y Kitamura and K Toyoshima
Department of Oncogene Research, Osaka University, Suita, Japan.
The cell types expressing cot proto-oncogene mRNA were identified by in situ hybridization (ISH) histochemistry. Among a variety of adult mouse tissues examined, four types of glandular cells expressing cot gene were identified: (1) granular duct cells in the submandibular and sublingual glands; (2) serous cells in the parotid gland; (3) peptic (chief) cells in gastric glands; and (4) goblet cells in colonic glands. Investigation of the developmentally regulated expression of cot mRNA using tissues of 14-day and 18-day embryos, newborn and weanling mice showed that cot gene is expressed only in morphologically differentiated and functionally activated cells of these four types. No other types of cells showing ISH signals were observed. Based on these results, cot gene expressions in cultured cells of colonic adenocarcinomas and gastric adenocarcinomas were examined. SW 480 and WiDr cells showed high expression of this gene and so should be useful for functional analysis of Cot kinase. The expression patterns of cot gene in tumor tissues of the parotid gland, and gastric and colonic glands were investigated. Two of the tissues overexpressed this gene markedly, suggesting that overproduction of Cot kinase may be one cause of their transformation.
This article has been cited by other articles:
![]() |
K. M. Lee, K. W. Lee, A. M. Bode, H. J. Lee, and Z. Dong Tpl2 Is a Key Mediator of Arsenite-Induced Signal Transduction Cancer Res., October 15, 2009; 69(20): 8043 - 8049. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Munshi, J. F. Kurland, T. Nishikawa, P. J. Chiao, M. Andreeff, and R. E. Meyn Inhibition of constitutively activated nuclear factor-{kappa}B radiosensitizes human melanoma cells Mol. Cancer Ther., August 1, 2004; 3(8): 985 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Kurland, D. W. Voehringer, and R. E. Meyn The MEK/ERK Pathway Acts Upstream of NF{kappa}B1 (p50) Homodimer Activity and Bcl-2 Expression in a Murine B-Cell Lymphoma Cell Line: MEK INHIBITION RESTORES RADIATION-INDUCED APOPTOSIS J. Biol. Chem., August 22, 2003; 278(34): 32465 - 32470. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Eliopoulos, C. Davies, S. S. M. Blake, P. Murray, S. Najafipour, P. N. Tsichlis, and L. S. Young The Oncogenic Protein Kinase Tpl-2/Cot Contributes to Epstein-Barr Virus-Encoded Latent Infection Membrane Protein 1-Induced NF-{kappa}B Signaling Downstream of TRAF2 J. Virol., March 27, 2002; 76(9): 4567 - 4579. [Abstract] [Full Text] [PDF] |
||||